本文分析在全程规律用药下,影响短化疗效,造成失败、复发因素。以我院历年参加全国短化及抗结核新药科研入选的240例,完成疗程者209例作为分析对象,疗前痰菌浓缩全部阳性,均为浸润型肺结核,伴空洞者85例。入选病例大部住院,少数住院6个月痰阴转出院在本院门诊全监或全程用药并随访。治疗方法按全国短化及新药科研要求,随机分配各治疗组。归纳为①6月方案50例,②9月方案85例;③ This article analyzes the law in the whole medication, the impact of shortening the efficacy, resulting in failure, relapse factors. In our hospital over the years to participate in national shortening and antituberculosis drug research selected 240 cases, 209 cases completed the course of treatment as the analysis of objects, sputum bacteria before treatment are all positive, are infiltrative pulmonary tuberculosis, with empty hole in 85 cases. Most of the selected cases were hospitalized, a small number of hospitalized sputum yin 6 months out of hospital in the hospital outpatient supervision or full medication and follow-up. Treatment methods According to the national short-term and new drug research requirements, random distribution of the treatment group. Summarized as ① June program 50 cases, ② September program 85 cases; ③